On February 23, Petra Krutilova, MD; Alexander Markov, MD; Janet B. McGill, MD; Alexis McKee, MD; and previous fellow, Andrea Cedeno, MD had their research article titled “Interruption of CGM: Frequency and Adverse Consequences,” published by the Journal of Diabetes Science and Technology.
In this manuscript, they analyze the results of a survey completed by 99 adult patients of the Diabetes Center at Washinton University, with type 1 or type 2 diabetes who utilize continuous glucose monitoring (CGM).
The authors noted that CGM interruption was the rule rather than the exception. Furthermore, “prescription and dispensing practices provide an exact number of sensors per month without redundancy to account for the realities of daily CGM use.”
In summary, they state that “disruption in CGM use is common,” and that the “lack of redundancy of CGM supplies contributes to care disruption and adverse glycemic events.”
Markov AM, Krutilova P, Cedeno AE, McGill JB, McKee AM. Interruption of CGM: Frequency and Adverse Consequences. Journal of Diabetes Science and Technology. 2023;0(0). doi:10.1177/19322968231156572